Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1386 in Osteoarthritis of the Knee
NCT00878501Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Mar 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of AZD-1386 in osteoarthritis (OA), sponsored by AstraZeneca. Started Mar 2009; status: terminated.
02
Drugs
AZD-1386
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00878501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878501.